Dr Katherine Boylan is Director of Innovation for Manchester University NHS Foundation Trust (MFT), a position she has held since April 2020. This role involves overseeing innovation activities within MFT, part of the wider research and innovation function.

The Innovation Team in MFT supports: intellectual property and commercialisation management; adoption of novel technologies within the Trust; strategic partnerships (with commercial organisations and other leading clinical/academic centres); a portfolio of strategic programmes (including the Diagnostic and Technology Accelerator and Clinical Data Science Unit) and the interaction with the co-located companies across the Citylabs innovation district.

Prior to this position, Katherine worked in the University of Manchester for a number of years, most recently as Operations Director for the Medical Research Council funded Molecular Pathology Node, and the Trust-funded Diagnostics and Technology Accelerator. Katherine’s academic background is cancer genetics (PhD, University of Dundee) and molecular biology (BSc, University of Sheffield).